Table 2 Identified themes for question 1: barriers to antigen identification in CHP
Theme | Number of barriers in the theme (n = 60) |
|---|---|
Unclear significance of identified exposures | 9 |
Gaps in clinical knowledge and testing capabilities | 12 |
There are still many unknown and undiscovered antigens | 5 |
Problems with obtaining an accurate and comprehensive exposure history | 12 |
Patient limitations, financial barriers and lack of resources | 11 |
Individual patient beliefs, emotions, and attachments to antigen source | 5 |
Problems with environmental inspections and testing | 6 |